{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:00:31Z","timestamp":1754154031397,"version":"3.41.2"},"reference-count":61,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780443235443"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.pmbts.2023.12.004","type":"book-chapter","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T10:25:27Z","timestamp":1706091927000},"page":"295-309","source":"Crossref","is-referenced-by-count":0,"title":["RNA therapeutics for diarrhea"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pmbts.2023.12.004_bib1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1473-3099(17)30276-1","article-title":"Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015","volume":"17","author":"Diseases Collaborators","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.12.004_bib2","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/INF.0000000000001232","article-title":"A systematic review of the effect of rotavirus vaccination on diarrhea outcomes among children younger than 5 years","volume":"35","author":"Lamberti","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.12.004_bib3","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.09.020801","article-title":"Drivers of the reduction in childhood diarrhea mortality 1980-2015 and interventions to eliminate preventable diarrhea deaths by 2030","volume":"9","author":"Black","year":"2019","journal-title":"J Glob Health"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.12.004_bib4","first-page":"605","article-title":"The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data","volume":"60","author":"Snyder","year":"1982","journal-title":"Bull World Health Organ"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.12.004_bib5","article-title":"Chronic diarrhea","volume":"50","author":"Chu","year":"2020","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.12.004_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/flgastro-2017-100808","article-title":"Challenging current views on bile acid diarrhoea and malabsorption","volume":"9","author":"Kurien","year":"2018","journal-title":"Frontline Gastroenterol"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.12.004_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1053\/j.gastro.2016.10.014","article-title":"Pathophysiology, evaluation, and management of chronic watery diarrhea","volume":"152","author":"Camilleri","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.pmbts.2023.12.004_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4614-4726-9_5","article-title":"Diarrhea among children in developing countries","volume":"764","author":"Nataro","year":"2013","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.004_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MOG.0b013e32835a352f","article-title":"Hospital management of children with acute gastroenteritis","volume":"29","author":"Bruzzese","year":"2013","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.12.004_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11894-004-0083-5","article-title":"The use of oral rehydration solutions in children and adults","volume":"6","author":"Sentongo","year":"2004","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.12.004_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/cpt1972133407","article-title":"Pharmacokinetics and metabolism of diphenoxylate in man","volume":"13","author":"Karim","year":"1972","journal-title":"Clin Pharmacol Ther"},{"issue":"9209","key":"10.1016\/bs.pmbts.2023.12.004_bib12","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(00)02033-X","article-title":"Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial","volume":"355","author":"Camilleri","year":"2000","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.12.004_bib13","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-2036.1998.00375.x","article-title":"Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome","volume":"12","author":"Delvaux","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"issue":"6a","key":"10.1016\/bs.pmbts.2023.12.004_bib14","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1016\/0002-9343(90)90270-N","article-title":"Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea.","volume":"88","author":"DuPont","year":"1990","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/bs.pmbts.2023.12.004_bib15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2036.2007.03261.x","article-title":"Review article: the history of acute infectious diarrhoea management\u2014from poorly focused empiricism to fluid therapy and modern pharmacotherapy","volume":"25","author":"McMahan","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.004_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1086\/504921","article-title":"Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status","volume":"194","author":"Johnson","year":"2006","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.12.004_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3201\/eid1302.060587","article-title":"Campylobacter antimicrobial drug resistance among humans, broiler chickens, and pigs, France","volume":"13","author":"Gallay","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/bs.pmbts.2023.12.004_bib18","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/00005176-200110002-00004","article-title":"Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials","volume":"33","author":"Szajewska","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.12.004_bib19","article-title":"Probiotics for treating acute infectious diarrhoea","volume":"2010","author":"Allen","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.12.004_bib20","doi-asserted-by":"crossref","first-page":"e1155","DOI":"10.1542\/peds.2011-1379","article-title":"Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children","volume":"129","author":"Agustina","year":"2012","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.12.004_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s12276-022-00757-5","article-title":"RNA therapy: rich history, various applications and unlimited future prospects","volume":"54","author":"Kim","year":"2022","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.004_bib22","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41467-019-08852-4","article-title":"Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes","volume":"10","author":"Gan","year":"2019","journal-title":"Nat Commun"},{"issue":"477","key":"10.1016\/bs.pmbts.2023.12.004_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9143","article-title":"Durable anticancer immunity from intratumoral administration of IL-23, IL-36\u03b3, and OX40L mRNAs","volume":"11","author":"Hewitt","year":"2019","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/bs.pmbts.2023.12.004_bib24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd.2018.132","article-title":"An RNA toolbox for cancer immunotherapy","volume":"17","author":"Pastor","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/bs.pmbts.2023.12.004_bib25","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2014developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.12.004_bib26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCRESAHA.119.315856","article-title":"Preclinical and clinical development of noncoding RNA therapeutics for cardiovascular disease","volume":"126","author":"Huang","year":"2020","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.004_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10010158","article-title":"Recent advances in RNA therapy and its carriers to treat the single-gene neurological disorders","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/bs.pmbts.2023.12.004_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00965","article-title":"The network of colonic host defense peptides as an innate immune defense against enteropathogenic bacteria","volume":"11","author":"Blyth","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.004_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.12.004_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/hum.2007.179","article-title":"Overcoming the innate immune response to small interfering RNA","volume":"19","author":"Judge","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1016\/bs.pmbts.2023.12.004_bib31","series-title":"siRNA and miRNA Gene Silencing: From Bench to Bedside","first-page":"1","article-title":"Deciphering the code of innate immunity recognition of siRNAs","author":"Sioud","year":"2009"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.12.004_bib32","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/ph6040440","article-title":"Design of siRNA therapeutics from the molecular scale","volume":"6","author":"Angart","year":"2013","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.004_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.12.004_bib34","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s00109-006-0084-y","article-title":"Toll-like receptors and innate immunity","volume":"84","author":"Uematsu","year":"2006","journal-title":"J Mol Med"},{"key":"10.1016\/bs.pmbts.2023.12.004_bib35","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.4155\/fmc.14.116","article-title":"miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents","volume":"6","author":"Baumann","year":"2014","journal-title":"Future Med Chem"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.004_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00709-015-0931-1","article-title":"The crucial role and regulations of miRNAs in zebrafish development","volume":"254","author":"Bhattacharya","year":"2017","journal-title":"Protoplasma"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.12.004_bib37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.12.004_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.immuni.2007.02.005","article-title":"MicroRNAs and immunity: tiny players in a big field","volume":"26","author":"Taganov","year":"2007","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.12.004_bib39","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2174\/1567205014666170829101016","article-title":"miRNAs in Alzheimer disease\u2014a therapeutic perspective","volume":"14","author":"Gupta","year":"2017","journal-title":"Curr Alzheimer Res"},{"issue":"7330","key":"10.1016\/bs.pmbts.2023.12.004_bib40","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature09783","article-title":"Pervasive roles of microRNAs in cardiovascular biology","volume":"469","author":"Small","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.004_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-8-102","article-title":"MicroRNAs in colorectal cancer: translation of molecular biology into clinical application","volume":"8","author":"Slaby","year":"2009","journal-title":"Mol Cancer"},{"issue":"5\u20136","key":"10.1016\/bs.pmbts.2023.12.004_bib42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1440-1681.2006.04403.x","article-title":"Antisense oligonucleotides: from design to therapeutic application","volume":"33","author":"Chan","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/bs.pmbts.2023.12.004_bib43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-pharmtox-010716-104846","article-title":"Pharmacology of antisense drugs","volume":"57","author":"Bennett","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.12.004_bib44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.12.004_bib45","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41580-019-0131-5","article-title":"The next generation of CRISPR\u2013Cas technologies and applications","volume":"20","author":"Pickar-Oliver","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/bs.pmbts.2023.12.004_bib46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J Mol Evol"},{"issue":"7280","key":"10.1016\/bs.pmbts.2023.12.004_bib47","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature08703","article-title":"Self versus non-self discrimination during CRISPR RNA-directed immunity","volume":"463","author":"Marraffini","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.12.004_bib48","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"issue":"6213","key":"10.1016\/bs.pmbts.2023.12.004_bib49","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2023.12.004_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112743","article-title":"Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections","volume":"148","author":"Najafi","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.12.004_bib51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(91)90016-F","article-title":"The potential use of catalytic RNAs in therapy of HIV infection and other diseases","volume":"50","author":"Rossi","year":"1991","journal-title":"Pharmacol Ther"},{"issue":"6498","key":"10.1016\/bs.pmbts.2023.12.004_bib52","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/371619a0","article-title":"Ribozyme-mediated repair of defective mRNA by targeted trans-splicing","volume":"371","author":"Sullenger","year":"1994","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2023.12.004_bib53","first-page":"175","article-title":"Ribozymes","volume":"29","author":"James","year":"1995","journal-title":"Essays Biochem"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.004_bib54","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/15476286.2022.2058818","article-title":"Insights into the secondary and tertiary structure of the Bovine Viral Diarrhea Virus Internal Ribosome Entry Site","volume":"19","author":"Gosavi","year":"2022","journal-title":"RNA Biol"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.12.004_bib55","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrgastro.2015.111","article-title":"Secretory diarrhoea: mechanisms and emerging therapies","volume":"12","author":"Thiagarajah","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"year":"2018","series-title":"Water Transport in the Gastrointestinal Tract: Physiology of the Gastrointestinal Tract","author":"Thiagarajah","key":"10.1016\/bs.pmbts.2023.12.004_bib56"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.12.004_bib57","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ymthe.2019.03.009","article-title":"In vitro-transcribed mRNA therapeutics: out of the shadows and into the spotlight","volume":"27","author":"Karik\u00f3","year":"2019","journal-title":"Mol Ther"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.12.004_bib58","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics\u2014challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/bs.pmbts.2023.12.004_bib59","first-page":"161","article-title":"The limitless future of RNA therapeutics","author":"Damase","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"issue":"12","key":"10.1016\/bs.pmbts.2023.12.004_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004656","article-title":"The siRNA non-seed region and its target sequences are auxiliary determinants of off-target effects","volume":"11","author":"Kamola","year":"2015","journal-title":"PLoS Comput Biol"},{"issue":"7092","key":"10.1016\/bs.pmbts.2023.12.004_bib61","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"}],"container-title":["Progress in Molecular Biology and Translational Science","RNA Therapeutics Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117323001862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117323001862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T19:07:18Z","timestamp":1753297638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117323001862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443235443"],"references-count":61,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2023.12.004","relation":{},"ISSN":["1877-1173"],"issn-type":[{"type":"print","value":"1877-1173"}],"subject":[],"published":{"date-parts":[[2024]]}}}